Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin Dose-Finding Study in T2DM on Metformin
NCT00749190Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 2 trial of empagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Aug 2008; status: completed.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00749190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749190.